activation of pi3kakt and mapk pathway through a pdgfrβ-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma激活pi3kakt和mapk通路通过pdgfrβ-dependent反馈回路参与在肝细胞癌雷帕霉素抵抗.pdfVIP

activation of pi3kakt and mapk pathway through a pdgfrβ-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma激活pi3kakt和mapk通路通过pdgfrβ-dependent反馈回路参与在肝细胞癌雷帕霉素抵抗.pdf

  1. 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
activation of pi3kakt and mapk pathway through a pdgfrβ-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma激活pi3kakt和mapk通路通过pdgfrβ-dependent反馈回路参与在肝细胞癌雷帕霉素抵抗

Activation of PI3K/AKT and MAPK Pathway through a PDGFRb-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular Carcinoma 1,2. 1. 1. 1. 2 1 Quan-Lin Li , Fang-Ming Gu , Zheng Wang , Jia-Hao Jiang , Li-Qing Yao , Chang-Jun Tan , 1 1 1,3 1,3 1,3 Xiao-Yong Huang , Ai-Wu Ke , Zhi Dai , Jia Fan *, Jian Zhou * 1 Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, People’s Republic of China, 2 Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China, 3 Shanghai Key Laboratory of Organ Transplantation, Shanghai, People’s Republic of China Abstract Background: Rapamycin is an attractive approach for the treatment and prevention of HCC recurrence after liver transplantation. However, the objective response rates of rapamycin achieved with single-agent therapy were modest, supporting that rapamycin resistance is a frequently observed characteristic of many cancers. Some studies have been devoted to understanding the mechanisms of rapamycin resistance, however, the mechanisms are cell-type-dependent and studies on rapamycin resistance in HCC are extremely limited. Methodology/Principal Findings: The anti-tumor sensitivity of rapamycin was modest in vitro and in vivo. In both human and rat HCC cells, rapamycin up-regulated the expression and phosphorylation of PDGFRb in a time and dose-depende

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档